CEO and CMO Increase Stake to 2.8% via Option Exercise, Affirming Control
NIVF is trading near its 52-week low of $0.511 (3.2% above the low) on elevated volume (8.2× avg).
Summary
NewGenIvf Group's CEO and CMO increased their combined stake to 2.8% of Class B shares by exercising options, explicitly stating their intent to retain control.
Key Events · Ownership and Investor Activity · NIVF
-
CEO and CMO Increase Stake
Wing Fung Alfred Siu (Chairman & CEO) and Hei Yue Tina Fong (Director & CMO) collectively increased their beneficial ownership to 113,771 Class B ordinary shares, representing 2.8% of the class.
-
Option Exercise at Nominal Price
The increase resulted from exercising 113,702 share options on June 4, 2026, at a nominal exercise price of $0.0001 per share, converting existing rights into direct equity.
-
Affirmation of Control
The reporting persons explicitly stated their purpose for holding the shares is to retain control of the Issuer.
-
Commitment Amidst Challenges
This insider commitment occurs while the company faces a "going concern" warning and its stock trades near 52-week lows, following recent strategic investments.
Analysis · NIVF · Industrial Applications And Services
The CEO and CMO have increased their beneficial ownership in NewGenIvf Group to 2.8% of Class B ordinary shares by exercising options. This move, while an option exercise rather than an open market purchase, is significant given the company's micro-cap status and recent "going concern" warning. It signals a commitment from top management to retain control amidst challenging financial conditions, especially as the stock trades near its 52-week low, and follows recent strategic investments in K25.ai.
At the time of this filing, NIVF was trading at $0.53 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $362.8K. The 52-week trading range was $0.51 to $888.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.